PAM SPECIALTY HOSPITAL OF LAS VEGAS — History
CCN 292006 | 3-year financial timeline | COVID resilience: 33/100
🛡️ Public data only — no PHI permitted on this instance.
$38M
Latest Revenue (FY2022)
-6.8%
Revenue CAGR (3yr)
10.1%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $44M | $43M | $38M | -12.1% | -6.8% |
| Operating Expenses | $37M | $37M | $34M | -8.7% | -4.5% |
| Operating Margin | 14.4% | 13.4% | 10.1% | -24.8% | -16.5% |
| Net Income | $6M | $6M | $4M | -33.9% | -22.2% |
| Licensed Beds | 70 | 70 | 70 | +0.0% | +0.0% |
| Total Patient Days | 22,296 | 20,980 | 18,198 | -13.3% | -9.7% |
| Medicare Day % | 62% | 58% | 60% | +3.2% | -1.8% |
| Medicaid Day % | 2% | 1% | 1% | +48.2% | -17.1% |
COVID Impact & Recovery
Resilience Score: 33/100 — Distressed — significant COVID damage
Revenue recovery from FY2020 to FY2022: -13.2% ($44M → $38M)
FY2020 captured the initial COVID shock. Slow recovery suggests structural challenges beyond COVID.
Trend Summary
Revenue▼ Declining
Operating Margin▼ Declining
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
-6.8%
This Hospital
+7.6%
State Avg
Latest Margin
10.1%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $35M | 7.9% |
| FY2024 (proj) | $32M | 5.7% |
| FY2025 (proj) | $29M | 3.5% |